Dow Up 2.00% Nasdaq Up 1.66%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
141.11 Up 5.75(4.25%) Feb 12, 3:59PM EST
|After Hours : 141.14 Up 0.03 (0.02%) Feb 12, 5:04PM EST
Prev Close:135.36
Open:136.91
Bid:132.00 x 100
Ask:141.12 x 200
1y Target Est:206.11
Beta:1.59616
Earnings Date:Apr 21 - Apr 25 (Est.)
Day's Range:134.31 - 141.26
52wk Range:130.51 - 208.88
Volume:1,595,206
Avg Vol (3m):1,651,050
Market Cap:31.79B
P/E (ttm):210.61
EPS (ttm):0.67
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALXNUp 4.25%31.79B
AMGNUp 2.30%109.12B
BAXUp 2.03%20.03B

Key Statistics

Forward P/E (1 yr):20.51
P/S (ttm):11.71
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :5.19
Quarterly EPS Est (Mar-16) :1.13
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.30

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback